Juno Therapeutics (JUNO) Stock: Here’s What You Need To Know

Juno Therapeutics (NASDAQ: JUNO) On July 12, 2016 it was announced that the FDA had released the clinical hold for the company’s lead drug candidate ¬†JCAR015. A few weeks prior the FDA had put Juno’s trial, known as ROCKET, on a clinical hold because there were two patient deaths in the trial. The company proclaimed … Read more

Biotech Stock News (ANAC) (CELG) (RCPT) (JUNO) (AMGN)

Anacor Pharmaceuticals (NASDAQ:ANAC) On Monday July 13, 2015 shares of Anacor went up 55%, closing around $131.93 per share after the company announced positive phase 3 results in patients who have atopic dermatitis. There were two phase 3 trials that were testing Anacor’s drug, Crisaborole, for these patients with atopic dermatitis — also known as … Read more

Biotech Stock News (SRPT) (JUNO) (CELG) (AGTC) (VRTX)

Sarepta Therapeutics (NASDAQ:SRPT) On Monday June 29, 2015 Sarepta had announced that it had completed¬†its rolling submission of its New Drug Application — NDA — to the FDA. A rolling submission is an FDA policy whereby biotech companies can submit their marketing approval application in small parts on a rolling basis instead of doing it … Read more